Abstract
Background and ObjectivesAgonistic autoantibodies against the angiotensin receptor type 1 (AT1R) and the endothelin receptor type A (ETAR) have been identified in the majority of systemic sclerosis (SSc) patients. We...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have